Thermo Fisher’s New Array Supports Population-Scale Disease Studies and Pharmacogenomics Research
The array combines four assays: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood and HLA typing
The array combines four assays: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood and HLA typing
Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.
The system produces microarrays for such applications as gene expression, genotyping, protein binding, and protein expression profiling.
Discovery show advantage of metabolic over genetic screening, say researchers.
Read MoreThe company has received regulatory approvals from both CLIA and New York State and will offer the genomic microarray as part of its Kidney Complete Program.
Read MoreRoche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
Read MoreLaboratory Corp of America Holdings, Burlington, NC, is offering a high-density microarray, Affymetrix-based technology (Whole-Genome Sampling Analysis).
Read More